Monday's Small-cap Movers under Crystal Research's Coverage

Posted by Laura Swartz

August 6, 2012 at 5:04 PM

CNBC today published an article wherein the founder of Vanguard Group discussed his view on the necessity of investing in equities, which while higher risk, offer the potential for higher reward.

"If you don't have money in the stock market (^GSPC) and you hope to retire someday, the founder of The Vanguard Group says you're making a big mistake. John 'Jack' Bogle tells us if you're investing for the long-term don't get spooked by events of late. "Knight Capital is meaningless for anyone in the market for the long haul," he says. "In fact, you're probably in a mutual fund and you can pat yourself on the back for being smart." In other words, for most individual investors the risk from Knight Capital is non- existent because most individuals hold a basket of stocks and the diversity of the basket hedges out the single stock risk."

-- "Avoiding Stocks Is a Big Mistake: Vanguard Founder" By Lee Brodie | CNBC 

Along those lines, roughly two stocks increased for every one that decreased on the NYSE today. An examination of the companies recently under our coverage found several significant gains for today, as highlighted in the table below (ticker/name/closing price/percent increase). For greater details on any of these companies, please view our coverage of them at


Adamis Pharmaceuticals Corporation




Advaxis, Inc.




Bioniche Life Sciences Inc.




PhotoMedex, Inc.




Peregrine Pharmaceuticals, Inc.




Pluristem Therapeutics, Inc.




T3 Motion, Inc.




Topics: Crystal Research Associates, T3 Motion, Advaxis, Bioniche, Pluristem Therapeutics, Peregrine, Adamis

Receive Our Research Notifications

About This Blog

We provide investor-based research and corporate communications services to companies worldwide. Visit our About Us page to learn more.

Posts by Date

see all

Posts by Topic